The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...

A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

The most familiar artificial intelligence (AI) applications include text generation, facial recognition, and autonomous driving. But there are other AI applications that deserve their share of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...